Skip to main content

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Introduction

A nine-person jury panel held J&J and its Ethicon Inc. subsidiary responsible for being negligent in designing and marketing of Prolift, a transvaginal mesh device, which caused chronic pelvic pain since the time the plaintiff underwent a prolapse repair surgery in 2009. The jury pointed that the defendants marketed, sold, and recruited physicians worldwide to implant the mesh implant device for Pelvic Floor Repair in women that suffered from pelvic prolapse. The plaintiff was awarded $10 million as compensatory and $25 million as punitive damages in the U.S. District Court for the Northern District of Indiana Judiciary, with Honorable Judge Philip P. Simon presiding over the 9-day trial.

Over 55,000 product liability claims involving Prolift and other transvaginal mesh implants are a part of the centralized litigation in the U.S. District Court for the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!